Liquid chromatography-tandem mass spectrometry analysis of free and esterified fatty acid N-acyl ethanolamines in plasma and blood cells

Analytical Biochemistry

Volumn 434, Issue 2, 2013, Pages 275-283

  Balvers, Michiel G J ^a,b   Wortelboer, Heleen M ^a   Witkamp, Renger F ^b   Verhoeckx, Kitty C M ^a  

^a TNO   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Diet; Endocannabinoids; LC MS MS; NAEs; Plasma; Validation

Indexed keywords

ALKANOLAMINES; CELLS; CYTOLOGY; ESTERS; LIQUID CHROMATOGRAPHY; MAMMALS; MASS SPECTROMETRY; NUTRITION; PLASMA (HUMAN); PLASMAS;

2-ARACHIDONOYL GLYCEROLS; ENDOCANNABINOIDS; LC-MS/MS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; N-3 FATTY ACIDS; NAES; SENSITIVE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; VALIDATION;

FATTY ACIDS;

2 ARACHIDONOYL GLYCEROL; ACETONITRILE; ARACHIDONOYL ETHANOLAMIDE; DIHOMO GAMMA LINOLENOYL ETHANOLAMIDE; DOCOSAHEXAENOYL ETHANOLAMIDE; ETHANOLAMINE DERIVATIVE; N ACYL ETHANOLAMINE; OLEOYL ETHANOLAMIDE; OMEGA 3 FATTY ACID; PALMITOYL ETHANOLAMIDE; STEAROYL ETHANOLAMIDE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CELL; CONTROLLED STUDY; ESTERIFICATION; EXTRACTION; HUMAN; LIPID COMPOSITION; LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; PLASMA; PRECIPITATION; PRIORITY JOURNAL; SAPONIFICATION; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS;

EID: 84873371906     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2012.11.008     Document Type: Article

References (39)

1. T. Bisogno Endogenous cannabinoids: structure and metabolism J. Neuroendocrinol. 20 2008 1 9
2. L. De Petrocellis, D. Melck, T. Bisogno, and V. Di Marzo Endocannabinoids and fatty acid amides in cancer, inflammation, and related disorders Chem. Phys. Lipids 108 2000 191 209
3. V. Di Marzo, and S. Petrosino Endocannabinoids and the regulation of their levels in health and disease Curr. Opin. Lipidol. 18 2007 129 140
4. S.E. O'Sullivan Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors Br. J. Pharmacol. 152 2007 576 582
5. A. Artmann, G. Petersen, L.I. Hellgren, J. Boberg, C. Skonberg, C. Nellemann, S.H. Hansen, and H.S. Hansen Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver, and small intestine Biochim. Biophys. Acta 1781 2008 200 212
6. M. Blüher, S. Engeli, N. Köting, J. Berndt, M. Fasshauer, S. Bátkai, P. Pacher, M.R. Schön, J. Jordan, and M. Stumvoll Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity Diabetes 55 2006 3053 3060
7. H.B. Bradshaw, N. Rimmerman, J.F. Krey, and J.M. Walker Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators Am. J. Physiol. Regul. Integr. Comp. Physiol. 291 2006 R349 R358
8. M.P. Gonthier, L. Hoareau, F. Festy, I. Matias, M. Valenti, S. Bès-Houtmann, C. Rouch, C. Robert-Da Silva, S. Chesne, C. Hellencourt, M. Cesari, V. Di Marzo, and R. Roche Identification of endocannabinoids and related compounds in human fat cells Obesity 15 2007 837 845
9. M. Joosten, M. Balvers, K. Verhoeckx, H. Hendriks, and R. Witkamp Plasma anandamide and other N-acylethanolamines are correlated with their corresponding free fatty acid levels under both fasting and non-fasting conditions in women Nutr. Metab. 7 2010 49
10. I. Matias, G. Carta, E. Murru, S. Petrosino, S. Banni, and V. Di Marzo Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes Biochim. Biophys. Acta 1781 2008 52 60
11. Y. Wang, Y. Liu, Y. Ito, T. Hashiguchi, I. Kitajima, M. Yamakuchi, H. Shimizu, S. Matsuo, H. Imaizumi, and I. Maruyama Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock Anal. Biochem. 294 2001 73 82
12. A.A. Zoerner, D.O. Stichtenoth, S. Engeli, S. Batkai, C. Winkler, F. Schaumann, J. Janke, O. Holz, N. Krug, D. Tsikas, J. Jordan, and J.M. Hohlfeld Allergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma Clin. Pharmacol. Ther. 90 2011 388 391
13. M.G.J. Balvers, K.C.M. Verhoeckx, and R.F. Witkamp Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry J. Chromatogr. B 877 2009 1583 1590
14. + coordination tandem mass spectrometry Anal. Biochem. 314 2003 8 15
15. P.M.W. Lam, T.H. Marczylo, M. El-Talatini, M. Finney, V. Nallendran, A.H. Taylor, and J.C. Konje Ultra performance liquid chromatography tandem mass spectrometry method for the measurement of anandamide in human plasma Anal. Biochem. 380 2008 195 201
16. J. Palandra, J. Prusakiewicz, J.S. Ozer, Y. Zhang, and T.G. Heath Endogenous ethanolamide analysis in human plasma using HPLC tandem MS with electrospray ionization J. Chromatogr. B 877 2009 2052 2060
17. D. Richardson, C.A. Ortori, V. Chapman, D.A. Kendall, and D.A. Barrett Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry Anal. Biochem. 360 2007 216 226
18. A. Schmidt, K. Brune, and B. Hinz Determination of the endocannabinoid anandamide in human plasma by high-performance liquid chromatography Biomed. Chromatogr. 20 2006 336 342
19. J. Williams, J. Wood, L. Pandarinathan, D. Karanian, B. Bahr, P. Vouros, and A. Makriyannis Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS Anal. Chem. 79 2007 5582 5593
20. J.T. Wood, J.S. Williams, L. Pandarinathan, A. Courville, M.R. Keplinger, D.R. Janero, P. Vouros, A. Makriyannis, and C.J. Lammi-Keefe Comprehensive profiling of the human circulating endocannabinoid metabolome: clinical sampling and sample storage parameters Clin. Chem. Lab. Med. 46 2008 1289 1295
21. A.A. Zoerner, S. Batkai, M.-T. Suchy, F.-M. Gutzki, S. Engeli, J. Jordan, and D. Tsikas Simultaneous UPLC-MS/MS quantification of the endocannabinoids 2-arachidonoyl glycerol (2AG), 1-arachidonoyl glycerol (1AG), and anandamide in human plasma: minimization of matrix effects, 2AG/1AG isomerization, and degradation by toluene solvent extraction J. Chromatogr. B 883-884 2012 161 171
22. G. Shearer, and J. Newman Impact of circulating esterified eicosanoids and other oxylipins on endothelial function Curr. Atheroscler. Rep. 11 2009 403 410
23. K.C.M. Verhoeckx, T. Voortman, M.G.J. Balvers, H.F.J. Hendriks, H.M. Wortelboer, and R.F. Witkamp Presence, formation, and putative biological activities of N-acyl serotonins, a novel class of fatty-acid derived mediators, in the intestinal tract Biochim. Biophys. Acta 2011 1811 578 586
24. M.G.J. Balvers, K.C.M. Verhoeckx, J. Meijerink, S. Bijlsma, C.M. Rubingh, H.M. Wortelboer, and R.F. Witkamp Time-dependent effect of in vivo inflammation on eicosanoid and endocannabinoid levels in plasma, liver, ileum, and adipose tissue in C57BL/6 mice fed a fish-oil diet Int. Immunopharmacol. 13 2012 204 214
25. M. Balvers, K. Verhoeckx, S. Bijlsma, C. Rubingh, J. Meijerink, H. Wortelboer, and R. Witkamp Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues Metabolomics 8 2012 1130 1147
26. A.A. Zoerner, F.-M. Gutzki, S. Batkai, M. May, C. Rakers, S. Engeli, J. Jordan, and D. Tsikas Quantification of endocannabinoids in biological systems by chromatography and mass spectrometry: a comprehensive review from an analytical and biological perspective Biochim. Biophys. Acta 2011 1811 706 723
27. M. Vogeser, D. Hauer, S.C. Azad, E. Huber, M. Storr, and G. Schelling Release of anandamide from blood cells Clin. Chem. Lab. Med. 44 2006 488 491
28. N. De Marchi, L. De Petrocellis, P. Orlando, F. Daniele, F. Fezza, and V. Di Marzo Endocannabinoid signalling in the blood of patients with schizophrenia Lipids Health Dis. 2 2003 5
29. D. Schreiber, S. Harlfinger, B.M. Nolden, C.W. Gerth, U. Jaehde, E. Schömig, J. Klosterkötter, A. Giuffrida, G. Astarita, D. Piomelli, and F. Markus Leweke Determination of anandamide and other fatty acyl ethanolamides in human serum by electrospray tandem mass spectrometry Anal. Biochem. 361 2007 162 168
30. M.P. Gillum, D. Zhang, X.M. Zhang, D.M. Erion, R.A. Jamison, C. Choi, J. Dong, M. Shanabrough, H.R. Duenas, D.W. Frederick, J.J. Hsiao, T.L. Horvath, C.M. Lo, P. Tso, G.W. Cline, and G.I. Shulman N-Acylphosphatidylethanolamine, a gut-derived circulating factor induced by fat ingestion, inhibits food intake Cell 135 2008 813 824
31. T. Bisogno, A. Ligresti, and V. Di Marzo The endocannabinoid signalling system: biochemical aspects Pharmacol. Biochem. Behav. 81 2005 224 238
32. N. Ueda, K. Tsuboi, and T. Uyama Enzymological studies on the biosynthesis of N-acylethanolamines Biochim. Biophys. Acta 2010 1801 1274 1285
33. G.C. Shearer, and J.W. Newman Lipoprotein lipase releases esterified oxylipins from very low-density lipoproteins Prostaglandins Leukot. Essent Fatty Acids 79 2008 215 222
34. S. Banni, G. Carta, E. Murru, L. Cordeddu, E. Giordano, A. Sirigu, K. Berge, H. Vik, K. Maki, V. Di Marzo, and M. Griinari Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects Nutr. Metab. 8 2011 7
35. B. Batetta, M. Griinari, G. Carta, E. Murru, A. Ligresti, L. Cordeddu, E. Giordano, F. Sanna, T. Bisogno, S. Uda, M. Collu, I. Bruheim, V. Di Marzo, and S. Banni Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats J. Nutr. 139 2009 1495 1501
36. A. Berger, G. Crozier, T. Bisogno, P. Cavaliere, S. Innis, and V. Di Marzo Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets Proc. Natl. Acad. Sci. USA 98 2001 6402 6406
37. J.T. Wood, J.S. Williams, L. Pandarinathan, D.R. Janero, C.J. Lammi-Keefe, and A. Makriyannis Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma J. Lipid Res. 51 2010 1416 1423
38. J. Meijerink, P. Plastina, J.-P. Vincken, M. Poland, M. Attya, M.G.J. Balvers, H. Gruppen, B. Gabriele, and R. Witkamp The ethanolamide metabolite of DHA, docosahexaenoylethanolamine, shows immunomodulating effects in mouse peritoneal and RAW264.7 macrophages: evidence for a new link between fish oil and inflammation Br. J. Nutr. 105 2011 1789 1807
39. M.T. Cencioni, V. Chiurchiu, G. Catanzaro, G. Borsellino, G. Bernardi, L. Battistini, and M. Maccarrone Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors PLoS One 5 2010 e8688